Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

JUNE 19, 2022

The market for psychedelic substances is projected to grow rapidly, potentially outpacing the legal US cannabis market. For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

SpeedWeed

MAY 22, 2021

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. . View original article.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

The Cannigma

FEBRUARY 2, 2021

In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Fifty-one percent of the respondents to the questionnaire indicated that they knew of the legality of medical cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Veriheal

MAY 26, 2022

With new and improved products popping up left and right, legalization initiatives taking off all over the globe, and harmful “stoner” stigmas quickly dissipating, it’s clear that cannabis has entered a new era. That’s because cannabis affects everyone differently, and understanding these variations is critical for effective treatment plans.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

JULY 12, 2021

According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. At this time, there is little in the way for combat-related PTSD treatment specifically. A study conducted by Miriam Reisman reported that between 13.5%

Treatment 104

Treatment Sleep Clinical Trials Data 104

The Joint Blog

FEBRUARY 11, 2022

The legal status of the plant has made the reliable study of the full potential of this amazing compound problematic in the past. With more corners of the world coming around and legalizing the use of CBD for research and treatment of various conditions, a greater understanding of its potential for good is just now becoming apparent.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Cannabis Law Report

AUGUST 18, 2022

Among the first in the nation, Phillips Lytle’s Psychedelics Practice Team combines expertise in pharmaceutical science, FDA regulations and risk management to serve the legal needs of emerging bio-tech sectors. Promising research in psychedelics as a mental health treatment accelerates growth of industry in need of legal counsel.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

CannaMD

OCTOBER 29, 2020

On the contrary, after analyzing cross-sectional data from two population-based surveys including over 50,000 respondents, the American Journal of Epidemiology reports: The proportion of obese participants decreased with the frequency of cannabis use. Cannabis: 3. Shaking with fear! Find Out if You Qualify. Get Started. Join 65K+ Subscribers!

Research and Development 92

Research and Development Blood Pressure Data Clinical Trials 92

Cannabis Law Report

JANUARY 12, 2022

As Oregon prepares to roll out the nation’s first legal psilocybin-assisted services program, there is a recognized need for the community to track adverse events and measure efficacy. Through the right mix of regulation, technology, and data, both are equally achievable,” says NPA CEO Britt Rollins.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. However, a result can be statistically significant but not clinically significant–meaning that even though a study may detect a difference on paper, it may make no tangible difference in real-world application.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. The company initiated the first legal transfer (as deemed by federal law) to the U.S. .” territories. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

AUGUST 29, 2019

It has been just over a month since the public comment period closed in the wake of the public hearing held by the FDA, “Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds”. the perfect legal partner ®. It will be interesting to see what the agency gleans from the docket. Attorneys At Law.

Food 45

Food Hemp CBD Clinical Trials 45

CannaMD

NOVEMBER 6, 2019

The study, which surveyed more than 120,000 individuals, sought to determine whether those who lived in states where medical marijuana was legal were less likely or more likely to turn to opioids for pain relief. Medical cannabis is an effective and safe alternative for pain treatment. million to 11.4 million to 11.4 More Information.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Law Report

JULY 29, 2021

CB4 products are backed by scientific performance data and include CB4 Relief and CB4 Relief-T oral CBD Softgel capsules formulated with VESIsorb® technology, as well as topical CB4 Relief Deep Rub Gel formulated with enhanced skin permeation technology for maximum absorption through the skin. About Heritage Cannabis Holdings Corp.

Recreational 98

Recreational Vaping Concentrates Clinical Trials 98

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

The Joint Blog

JANUARY 12, 2020

Passage of the 2018 Farm Bill, which eased federal legal restrictions on hemp cultivation and transport, unleashed a stampede of companies rushing products to the market in an absence of regulations ensuring safety, quality and effectiveness. “The There’s a gold rush going on now. It’s really the Wild West out there,” said S.

Pets 36

Pets CBD Clinical Trials Research and Development 36

The Blunt Truth

AUGUST 13, 2019

The FDA has provided clarity that hulled hemp seed, hemp protein powder, and hemp seed oil can be legally used in foods. To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”. The FDA is collecting data to fill these gaps.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

JULY 9, 2022

For Jessica Thornton, who has lived with treatment-resistant depression since her senior year at high school, psychedelics represent a lifeline. I found that Johns Hopkins and other major research universities were doing clinical studies on psilocybin and treatment-resistant depression.”.

Microdosing 52

Microdosing Wellness and Beauty Research and Development Clinical Trials 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

CannaTech

SEPTEMBER 16, 2018

What began as a legal medicine more than 15 years is now being legalized for adult recreational use. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. The Need for Cannabis Education Tailored to Patient and Doctor.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

DECEMBER 2, 2021

Practicum training is a major focus of the proposed training curriculum, and as the program matures, students will observe and facilitate psilocybin treatment sessions under the supervision of a Practicum Site Supervisor. Programs shall train students in the legal requirements of Oregon’s Measure 109.

Law 52

Law Programs Therapy Education 52

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. As many as 250 clinics across the U.S.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Greencamp

AUGUST 16, 2018

Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Greencamp

FEBRUARY 2, 2019

Drugs used for the treatment of HIV and AIDS are called antiretroviral medications, and there are several different classes of these drugs: Fusion/Entry Inhibitors (they prevent, or more precisely slow down HIV from entering healthy cells). But I haven’t seen any clinical trials looking at the direct effects of THC on the virus.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

JULY 23, 2019

In cases where the product is illegal under some federal laws, but legal under some state and federal laws, marketing is complicated. There is no uniform set of state laws for marketing legal cannabis at this time. This is particularly the case for cannabis and cannabidiol (CBD) products. She lost her job as a result.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

JULY 24, 2019

321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body. March 25, 2019 posting – “CBD is being adopted more and more as a natural alternative to pharmaceutical-grade treatments for depression and anxiety.”.

CBD 51

CBD Tincture Pets Chronic Pain 51